日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism

基因矫正导致原发性高草酸尿症的最常见突变可恢复酶定位和草酸代谢

Keskinen, Timo; Jalil, Sami; Gümüşoğlu, Irem; Juutila, Juhana; Kestilä, Nadim; Kuuluvainen, Emilia; Hietakangas, Ville; Balboa, Diego; Wartiovaara, Kirmo; Hyvönen, Mervi E

Vacuolar-type H(+)-ATPase-mediated extra-organellar buffering resolves mitochondrial dysfunction

液泡型H(+)-ATPase介导的细胞器外缓冲作用可解决线粒体功能障碍

Monteuuis, Geoffray; Awadhpersad, Ryan; van der Kolk, Daan; Singh, Sachin K; Nyman, Tuula A; Malyutina, Alina; Zamboni, Nicola; Moisio, Kari; Juutila, Juhana; Hietakangas, Ville; Seneca, Sara; Carroll, Christopher J; Jackson, Christopher B

Thymidylate synthase disruption to limit cell proliferation in cell therapies

胸苷酸合酶破坏可限制细胞疗法中的细胞增殖

Rocio Sartori-Maldonado, Hossam Montaser, Inkeri Soppa, Solja Eurola, Juhana Juutila, Melanie Balaz, Henri Puttonen, Timo Otonkoski, Jonna Saarimäki-Vire, Kirmo Wartiovaara

Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors

使用 CRISPR 腺嘌呤碱基编辑器对精氨琥珀酸裂解酶缺陷进行遗传和功能校正

Sami Jalil, Timo Keskinen, Juhana Juutila, Rocio Sartori Maldonado, Liliya Euro, Anu Suomalainen, Risto Lapatto, Emilia Kuuluvainen, Ville Hietakangas, Timo Otonkoski, Mervi E Hyvönen, Kirmo Wartiovaara

Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis

非药物干预措施在结缔组织疾病中的电子健康适用性:范围界定综述及描述性分析

Ritschl, Valentin; Ferreira, Ricardo J O; Santos, Eduardo José Ferreira; Fernandes, Rúben; Juutila, Essi; Mosor, Erika; Santos-Costa, Paulo; Fligelstone, Kim; Schraven, Linda; Stummvoll, Georg; Salvador, Maria; Poole, Janet L; van den Ende, Cornelia; Boström, Carina; Stamm, Tanja A